• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Model Number VBJR052502A
Medical Device Problem Code Detachment of Device or Device Component (2907)
Health Effect - Clinical Codes Stenosis (2263); No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 05/12/2022
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium apl, which in covalently bound to the device surface and is essentially|non-eluting.
 
Event or Problem Description
The following information was reported to gore: on (b)(6) 2022, a gore® viabahn® endoprosthesis (vsx device) was intended for use in the left superficial femoral artery for treatment of stenosis.After the device was successfully implanted, the physician removed the delivery catheter.Upon removal of the delivery catheter it was discovered that the distal tip had separated from the catheter inside the patient.An angiogram was performed and the distal tip was located in the implanted device.The decision was made to advance an additional 5mm x 5cm vsx device and pin the distal tip to the wall of the previously implanted vsx device.A final angiogram was performed to verify that the distal tip was pinned against the wall and the procedure was completed.The patient did not experience any adverse consequences.
 
Additional Manufacturer Narrative
Section h6 updated to reflect completion of investigation.Manufacturing records were reviewed, and the device met all pre-release specifications.The cause of the reported primary device failure mode, distal tip separation during removal, could not be confirmed.No items were returned for evaluation; however, the device serial number was provided allowing for a review of the bonding process for the device.Review of process data yielded no evidence of a missing distal tip bond.Further information regarding this event was requested by gore, but no further information has been reported, therefore this investigation is considered complete.
 
Additional Manufacturer Narrative
Revised h6: health effect - clinical code and investigation findings code.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® VIABAHN® ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE
Common Device Name
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
nick lafave
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key14606369
Report Number2017233-2022-02991
Device Sequence Number14595963
Product Code NIP
UDI-Device Identifier00733132623938
UDI-Public00733132623938
Combination Product (Y/N)Y
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
P040037
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2022
Reporter Type Manufacturer
Report Source Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 09/08/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date12/16/2024
Device Model NumberVBJR052502A
Device Catalogue NumberVBJR052502A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 05/12/2022
Supplement Date Received by Manufacturer07/13/2022
08/18/2022
Initial Report FDA Received Date06/06/2022
Supplement Report FDA Received Date07/13/2022
09/08/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured12/18/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient Age74 YR
Patient SexMale
-
-